These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6297210)

  • 1. Is the adrenal angiotensin receptor angiotensin II--or angiotensin III like?
    Braley LM; Menachery AI; Underwood RH; Williams GH
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):116-21. PubMed ID: 6297210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a heptapeptide angiotensin analog on aldosterone secretion in the rabbit.
    Neusy AJ; Pessah M; Steele JM; Lowenstein J
    Kidney Int; 1980 Jan; 17(1):66-73. PubMed ID: 6990089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of angiotensin II and angiotensin III in rabbit adrenal and aortic tissues.
    Pendleton RG; Gessner G; Horner E
    J Pharmacol Exp Ther; 1991 Feb; 256(2):614-20. PubMed ID: 1993998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of prolactin secretion from rat pituitary by luteinizing hormone-releasing hormone: evidence against mediation by angiotensin II acting through a (Sar1-Ala8)-angiotensin II-sensitive receptor.
    Robberecht W; Andries M; Denef C
    Neuroendocrinology; 1992 Aug; 56(2):185-94. PubMed ID: 1407372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of increases in intracellular calcium and aldosterone production induced by angiotensin II (AII): evidence for regulation by distinct AII receptor subtypes or isomorphs.
    Kocsis JF; Schimmel RJ; McIlroy PJ; Carsia RV
    Endocrinology; 1995 Apr; 136(4):1626-34. PubMed ID: 7895673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin peptides and prostaglandin E2 synthesis: modulation of neurogenic responses in the rabbit vas deferens.
    Saye J; Binder SB; Trachte GJ; Peach MJ
    Endocrinology; 1986 Nov; 119(5):1895-903. PubMed ID: 3464412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actions of angiotensin II antagonists upon aldosterone production by isolated adrenal glomerulosa cells.
    Saltman S; Fredlund P; Catt KJ
    Endocrinology; 1976 Apr; 98(4):894-903. PubMed ID: 1278097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulating effects of angiotensin I, angiotensin II and des-Asp1-angiotensin II on steroid production in vitro and its inhibition by Sar1-Ala8-angiotensin II.
    Hepp R; Grillet C; Peytremann A; Vallotton MB
    Prog Biochem Pharmacol; 1976; 12():41-8. PubMed ID: 1019169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin antagonists with increased specificity for the renal vasculature.
    Taub KJ; Caldicott WJ; Hollenberg NK
    J Clin Invest; 1977 Mar; 59(3):528-35. PubMed ID: 190270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of adenylate cyclase in rat adrenal glomerulosa cells by angiotensin II.
    Woodcock EA; Johnston CI
    Endocrinology; 1984 Jul; 115(1):337-41. PubMed ID: 6329657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II analogues and aldosterone secretion in sodium-deficient sheep.
    Blair-West JR; Coghlan JP; Denton DA; Niall HD; Scoggins BA; Tregear GW
    Clin Sci Mol Med Suppl; 1976 Dec; 3():325s-327s. PubMed ID: 1071638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin receptors in glomeruli differ from those in renal arterioles.
    Caldicott WJ; Taub KJ; Margulies SS; Hollenberg NK
    Kidney Int; 1981 May; 19(5):687-93. PubMed ID: 6270445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptidases and smooth muscle cell angiotensin II receptor pharmacology.
    Cohen RB; Webb ML; Dickinson KE
    Peptides; 1993; 14(2):345-52. PubMed ID: 8483812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (7-Ile) angiotensin III: a relatively selective antagonist of angiotensin steroidogenesis.
    Campbell WB; Schmitz JM
    Eur J Pharmacol; 1979 Mar; 54(3):209-16. PubMed ID: 218823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible implication of peptidase activity in different potency of angiotensins II and III for displacing [125I]angiotensin II binding in pig aorta.
    Fujimoto M; Mihara S; Shigeri Y; Itazaki K
    Eur J Pharmacol; 1992 May; 215(2-3):259-64. PubMed ID: 1396989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of two different angiotensin II antagonists on aldosterone secretion by isolated perfused rat zona glomerulosa cells.
    Boscaro M; Al-Dujaili EA; Edwards CR
    Endocrinology; 1981 Jun; 108(6):2381-4. PubMed ID: 6262059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are angiotensin receptors in vascular smooth muscles a homogeneous population?
    Tabrizchi R; Pang CC
    Eur J Pharmacol; 1987 Oct; 142(3):359-66. PubMed ID: 3428350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla.
    Balla T; Baukal AJ; Eng S; Catt KJ
    Mol Pharmacol; 1991 Sep; 40(3):401-6. PubMed ID: 1654513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats.
    Wright JW; Roberts KA; Cook VI; Murray CE; Sardinia MF; Harding JW
    Brain Res; 1990 Apr; 514(1):5-10. PubMed ID: 2357530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Competitive binding activity of angiotensin II analogues in an adrenal cortex radioligand-receptor assay;
    Saltman S; Baukal A; Waters S; Bumpus FM; Catt KJ
    Endocrinology; 1975 Aug; 97(2):275-82. PubMed ID: 169121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.